Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin - Top-Institutions - MDSpire

Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin

  • By

  • Jayastu Senapati

  • Elias Jabbour

  • Nicholas J. Short

  • Nitin Jain

  • Fadi Haddad

  • Tharakeswara Bathala

  • Iuliia Kovalenko

  • Aram Bidikian

  • Farhad Ravandi

  • Issa Khouri

  • Tapan M. Kadia

  • Rebecca Garris

  • Guillermo Montalban Bravo

  • Kelly Chien

  • Elizabeth Shpall

  • Partow Kebriaei

  • Hagop M. Kantarjian

  • August 7, 2024

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology-Oncology
    • Hepatology
    • Stem Cell Transplantation

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Hepatology
    • Transplant Medicine

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology-Oncology
    • Hepatology
    • Stem Cell Transplantation

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology-Oncology
    • Hepatology
    • Stem Cell Transplantation

  • #5

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Hematology-Oncology
    • Hepatology
    • Stem Cell Transplantation

Original Source(s)

Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin

  • by Jayastu Senapati, Elias Jabbour, Nicholas J. Short, Nitin Jain, Fadi Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan M. Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M. Kantarjian

  • August 7, 2024

Related Content

Borderline Liver Enzyme Patterns and Their Metabolic–Inflammatory Signatures: An Observational Outpatient Study

Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD

Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation